1-5 of 5
Arjan W. Griffioen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients

Arjan W. Griffioen, Laurie A. Mans, Annemarie M.A. de Graaf, Patrycja Nowak-Sliwinska, Céline L.M.M. de Hoog, Trees A.M. de Jong, Florry A. Vyth-Dreese, Judy R. van Beijnum, Axel Bex, Eric Jonasch
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (14): 3961–3971.
https://doi.org/10.1158/1078-0432.CCR-12-0002
Published: 15 July 2012
View articletitled, Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients
Open the PDF for Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients in another window
Includes: Supplementary data
Journal Articles

Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

Kristy J. Gotink, Henk J. Broxterman, Mariette Labots, Richard R. de Haas, Henk Dekker, Richard J. Honeywell, Michelle A. Rudek, Laurens V. Beerepoot, René J. Musters, Gerrit Jansen, Arjan W. Griffioen, Yehuda G. Assaraf, Roberto Pili, Godefridus J. Peters, Henk M.W. Verheul
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7337–7346.
https://doi.org/10.1158/1078-0432.CCR-11-1667
Published: 30 November 2011
View articletitled, Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
Open the PDF for Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance in another window
Includes: Supplementary data
Journal Articles

Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer

Ruud P.M. Dings, Kieng B. Vang, Karolien Castermans, Flavia Popescu, Yan Zhang, Mirjam G.A. oude Egbrink, Matthew F. Mescher, Michael A. Farrar, Arjan W. Griffioen, Kevin H. Mayo
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3134–3145.
https://doi.org/10.1158/1078-0432.CCR-10-2443
Published: 15 May 2011
View articletitled, Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer
Open the PDF for Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer in another window
Includes: Supplementary data
Journal Articles

Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization

Ruud P.M. Dings, Melissa Loren, Hanke Heun, Elizabeth McNiel, Arjan W. Griffioen, Kevin H. Mayo, Robert J. Griffin
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3395–3402.
https://doi.org/10.1158/1078-0432.CCR-06-2441
Published: 01 June 2007
View articletitled, Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization
Open the PDF for Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization in another window
Journal Articles

Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration

Jessica C. A. Bouma-ter Steege, Coen I. M. Baeten, Victor L. J. L. Thijssen, Sietske A. Satijn, Inge C. L. Verhoeven, Harry F. P. Hillen, John Wagstaff, Arjan W. Griffioen
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (21): 7171–7178.
https://doi.org/10.1158/1078-0432.CCR-04-0742
Published: 08 November 2004
View articletitled, Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration
Open the PDF for Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration in another window